|
1
|
Perri A, Vizza D, Lofaro D, Gigliotti P,
Leone F, Brunelli E, Malivindi R, De Amicis F, Romeo F, De Stefano
R, et al: Adiponectin is expressed and secreted by renal tubular
epithelial cells. J Nephrol. 26:1049–1054. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
von Eynatten M, Liu D, Hock C, Oikonomou
D, Baumann M, Allolio B, Korosoglou G, Morcos M, Campean V, Amann
K, et al: Urinary adiponectin excretion: A novel marker for
vascular damage in type 2 diabetes. Diabetes. 58:2093–2099. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rovin BH, Song H, Hebert LA, Nadasdy T,
Nadasdy G, Birmingham DJ, Yung Yu C and Nagaraja HN: Plasma, urine,
and renal expression of adiponectin in human systemic lupus
erythematosus. Kidney Int. 68:1825–1833. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen J, Tan B, Karteris E, Zervou S, Digby
J, Hillhouse EW, Vatish M and Randeva HS: Secretion of adiponectin
by human placenta: Differential modulation of adiponectin and its
receptors by cytokines. Diabetologia. 49:1292–1302. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yamauchi T, Kamon J, Ito Y, Tsuchida A,
Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et
al: Cloning of adiponectin receptors that mediate antidiabetic
metabolic effects. Nature. 423:762–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iwabu M, Yamauchi T, Okada-Iwabu M, Sato
K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata
M, et al: Adiponectin and AdipoR1 regulate PGC-1alpha and
mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 464:1313–1319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang CH, Chiu YC, Tan TW, Yang RS and Fu
WM: Adiponectin enhances IL-6 production in human synovial
fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B
pathway. J Immunol. 179:5483–5492. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao T, Gao Z, Gu L, Chen M, Yang B, Cao K,
Huang H and Li M: AdipoR1/APPL1 potentiates the protective effects
of globular adiponectin on angiotensin II-induced cardiac
hypertrophy and fibrosis in neonatal rat atrial myocytes and
fibroblasts. PLoS One. 9:e1037932014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farias JM, Maggi RM, Tromm CB, Silva LA,
Luciano TF, Marques SO, Lira FS, de Souza CT and Pinho RA: Exercise
training performed simultaneously to a high-fat diet reduces the
degree of insulin resistance and improves adipoR1-2/APPL1 protein
levels in mice. Lipids Health Dis. 11:1342012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu GZ, Liang B, Lau WB, Wang Y, Zhao J,
Li R, Wang X, Yuan Y, Lopez BL, Christopher TA, et al: High
glucose/High Lipids impair vascular adiponectin function via
inhibition of caveolin-1/AdipoR1 signalsome formation. Free Radic
Biol Med. 89:473–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perri A, Vizza D, Lupinacci S, Toteda G,
De Amicis F, Leone F, Gigliotti P, Lofaro D, La Russa A and
Bonofiglio R: Adiponectin secreted by tubular renal cells during
LPS exposure worsens the cellular inflammatory damage. J Nephrol.
29:185–194. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen YY, Hughes JT, Charlesworth JA, Kelly
JJ and Peake PW: Adiponectin is present in the urine in its native
conformation, and specifically reduces the secretion of MCP-1 by
proximal tubular cells. Nephrology (Carlton). 13:405–410. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cammisotto PG, Londono I, Gingras D and
Bendayan M: Control of glycogen synthase through ADIPOR1-AMPK
pathway in renal distal tubules of normal and diabetic rats. Am J
Physiol Renal Physiol. 294:F881–F889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Christou GA and Kiortsis DN: The role of
adiponectin in renal physiology and development of albuminuria. J
Endocrinol. 221:R49–R61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang F, Liu GC, Kim C, Yassa R, Zhou J and
Scholey JW: Adiponectin attenuates angiotensin II-induced oxidative
stress in renal tubular cells through AMPK and cAMP-Epac signal
transduction pathways. Am J Physiol Renal Physiol. 304:F1366–F1374.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sharma K, Ramachandra Rao S, Qiu G, Usui
HK, Zhu YQ, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al:
Adiponectin regulates albuminuria and podocyte function in mice. J
Clin Invest. 118:1645–1656. 2008.PubMed/NCBI
|
|
17
|
Rutkowski JM, Wang ZV, Park ASD, Zhang J,
Zhang D, Hu MC, Moe OW, Susztak K and Scherer PE: Adiponectin
promotes functional recovery after podocyte ablation. J Am Soc
Nephrol. 24:268–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohashi K, Iwatani H, Kihara S, Nakagawa Y,
Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, et
al: Exacerbation of albuminuria and renal fibrosis in subtotal
renal ablation model of adiponectin-knockout mice. Arterioscler
Thromb Vasc Biol. 27:1910–1917. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamada-Obara N, Yamagishi SI, Taguchi K,
Kaida Y, Yokoro M, Nakayama Y, Ando R, Asanuma K, Matsui T, Ueda S,
et al: Maternal exposure to high-fat and high-fructose diet evokes
hypoadiponectinemia and kidney injury in rat offspring. Clin Exp
Nephrol. 20:853–861. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yilmaz MI, Saglam M, Qureshi AR, Carrero
JJ, Caglar K, Eyileten T, Sonmez A, Cakir E, Oguz Y, Vural A, et
al: Endothelial dysfunction in type-2 diabetics with early diabetic
nephropathy is associated with low circulating adiponectin. Nephrol
Dial Transplant. 23:1621–1627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujita H, Morii T, Koshimura J, Ishikawa
M, Kato M, Miura T, Sasaki H, Narita T, Ito S and Kakei M: Possible
relationship between adiponectin and renal tubular injury in
diabetic nephropathy. Endocr J. 53:745–752. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu Y, Bao BJ, Fan YP, Shi L and Li SQ:
Changes of adiponectin and its receptors in rats following chronic
renal failure. Ren Fail. 36:92–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamei K, Konta T, Hirayama A, Suzuki K,
Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K,
et al: A slight increase within the normal range of serum uric acid
and the decline in renal function: Associations in a
community-based population. Nephrol Dial Transplant. 29:2286–2292.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li L, Chen Y, Zhao Y, Zeng X, Liu F and Fu
P: Is hyperuricemia an independent risk factor for new-onset
chronic kidney disease? A systematic review and meta-analysis based
on observational cohort studies. BMC Nephrol. 15:1–12. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chou YC, Kuan JC, Yang T, Chou WY, Hsieh
PC, Bai CH, You SL, Chen CH, Wei CY and Sun CA: Elevated uric acid
level as a significant predictor of chronic kidney disease: A
cohort study with repeated measurements. J Nephrol. 28:457–462.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hovind P, Rossing P, Tarnow L, Johnson RJ
and Parving HH: Serum uric acid as a predictor for development of
diabetic nephropathy in type 1 diabetes: An inception cohort study.
Diabetes. 58:1668–1671. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Madero M, Sarnak MJ, Wang X, Greene T,
Beck GJ, Kusek JW, Collins AJ, Levey AS and Menon V: Uric acid and
long-term outcomes in CKD. Am J Kidney Dis. 53:796–803. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shimada M, Johnson RJ, May WS Jr,
Lingegowda V, Sood P, Nakagawa T, Van QC, Dass B and Ejaz AA: A
novel role for uric acid in acute kidney injury associated with
tumour lysis syndrome. Nephrol Dial Transplant. 24:2960–2964. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cirillo P, Gersch MS, Mu W, Scherer PM,
Kim KM, Gesualdo L, Henderson GN, Johnson RJ and Sautin YY:
Ketohexokinase-dependent metabolism of fructose induces
proinflammatory mediators in proximal tubular cells. J Am Soc
Nephrol. 20:545–553. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han HJ, Lim MJ, Lee YJ, Lee JH, Yang IS
and Taub M: Uric acid inhibits renal proximal tubule cell
proliferation via at least two signaling pathways involving PKC,
MAPK, cPLA2, and NF-kappaB. Am J Physiol Renal Physiol.
292:F373–F381. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao J, Fu C, Zhang X, Zhu D, Chen W, Lu Y
and Ye Z: Soluble monosodium urate, but not its crystal, induces
toll like receptor 4-dependent immune activation in renal mesangial
cells. Mol Immunol. 66:310–318. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao J, Zhang XL, Fu CS, Han R, Chen WJ,
Lu YJ and Ye ZB: Soluble uric acid increases NALP3 inflammasome and
interleukin-1β expression in human primary renal proximal tubule
epithelial cells through the Toll-like receptor 4-mediated pathway.
Int J Mol Med. 35:1347–1354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eisenbacher JL, Schrezenmeier H,
Jahrsdörfer B, Kaltenmeier C, Rojewski MT, Yildiz T, Beyer T, Erle
A, Wiegmann DS, Grassl S, et al: S100A4 and uric acid promote
mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes. J
Immunol. 192:6102–6110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
National Research Council, . Guide for the
Care and Use of Laboratory Animals. The National Academies Press;
Washington, DC: 1996, https://www.nap.edu/read/5140/chapter/1
|
|
36
|
Yu P, Bu H, Wang H, Zhao G, Zhang J and
Zhou Q: Comparative study on image analysis and manual counting of
immunohistichemistry. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi.
20:288–290. 2003.(In Chinese). PubMed/NCBI
|
|
37
|
Scherer PE, Williams S, Fogliano M,
Baldini G and Lodish HF: A novel serum protein similar to C1q,
produced exclusively in adipocytes. J Biol Chem. 270:26746–26749.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hata A, Yonemoto K, Shikama Y, Aki N,
Kosugi C, Tamura A, Ichihara T, Minagawa T, Kuwamura Y, Miyoshi M,
et al: Cut-off value of total adiponectin for managing risk of
developing metabolic syndrome in male japanese workers. Plos One.
10:e01183732015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hayashi M, Shibata R, Takahashi H, Ishii
H, Aoyama T, Kasuga H, Yamada S, Ohashi K, Maruyama S, Matsuo S, et
al: Association of adiponectin with carotid arteriosclerosis in
predialysis chronic kidney disease. Am J Nephrol. 34:249–255. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zoico E, Garbin U, Olioso D, Mazzali G,
Fratta Pasini AM, Di Francesco V, Sepe A, Cominacini L and Zamboni
M: The effects of adiponectin on interleukin-6 and MCP-1 secretion
in lipopolysaccharide-treated 3T3-L1 adipocytes: Role of the
NF-kappaB pathway. Int J Mol Med. 24:847–851. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Iwasa Y, Otsubo S, Ishizuka T, Uchida K
and Nitta K: Influence of serum high-molecular-weight and total
adiponectin on arteriosclerosis in IgA nephropathy patients.
Nephron Clin Pract. 108:c226–c232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park CS, Ihm SH, Park HJ, Shin WS, Kim PJ,
Chang K, Kim HY, Youn HJ, Chung WS, Seung KB and Kim JH:
Relationship between plasma adiponectin, retinol-binding protein 4
and uric Acid in hypertensive patients with metabolic syndrome.
Korean Circ J. 41:198–202. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hosoya T, Ohno I, Nomura S, Hisatome I,
Uchida S, Fujimori S, Yamamoto T and Hara S: Effects of
topiroxostat on the serum urate levels and urinary albumin
excretion in hyperuricemic stage 3 chronic kidney disease patients
with or without gout. Clin Exp Nephrol. 18:876–884. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Baldwin W, McRae S, Marek G, Wymer D,
Pannu V, Baylis C, Johnson RJ and Sautin YY: Hyperuricemia as a
mediator of the proinflammatory endocrine imbalance in the adipose
tissue in a murine model of the metabolic syndrome. Diabetes.
60:1258–1269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tsioufis C, Kyvelou S, Dimitriadis K,
Syrseloudis D, Sideris S, Skiadas I, Katsi V, Stefanadi E, Lalos S,
Mihas C, et al: The diverse associations of uric acid with
low-grade inflammation, adiponectin and arterial stiffness in
never-treated hypertensives. J Hum Hypertens. 25:554–559. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nishizawa T, Taniura T and Nomura S:
Effects of febuxostat on platelet-derived microparticles and
adiponectin in patients with hyperuricemia. Blood Coagul
Fibrinolysis. 26:887–892. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jin X, Chen J, Hu Z, Chan L and Wang Y:
Genetic deficiency of adiponectin protects against acute kidney
injury. Kidney Int. 83:604–614. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yamauchi T, Kamon J, Minokoshi Y, Ito Y,
Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al:
Adiponectin stimulates glucose utilization and fatty-acid oxidation
by activating AMP-activated protein kinase. Nat Med. 8:1288–1295.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Martinez Cantarin MP, Keith SW, Waldman SA
and Falkner B: Adiponectin receptor and adiponectin signaling in
human tissue among patients with end-stage renal disease. Nephrol
Dial Transplant. 29:2268–2277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fang F, Bae EH, Hu A, Liu GC, Zhou X,
Williams V, Maksimowski N, Lu C, Konvalinka A, John R and Scholey
JW: Deletion of the gene for adiponectin accelerates diabetic
nephropathy in the Ins2 (+/C96Y) mouse. Diabetologia. 58:1668–1678.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tamura Y, Murayama T, Minami M, Matsubara
T, Yokode M and Arai H: Ezetimibe ameliorates early diabetic
nephropathy in db/db mice. J Atheroscler Thromb. 19:608–618. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Guo Z and Zhao Z: Effect of
N-acetylcysteine on plasma adiponectin and renal adiponectin
receptors in streptozotocin-induced diabetic rats. Eur J Pharmacol.
558:208–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ji H, Wu L, Ma X, Ma X and Qin G: The
effect of resveratrol on the expression of AdipoR1 in kidneys of
diabetic nephropathy. Mol Biol Rep. 41:2151–2159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Delaigle AM, Jonas JC, Bauche IB, Cornu O
and Brichard SM: Induction of adiponectin in skeletal muscle by
inflammatory cytokines: In vivo and in vitro studies.
Endocrinology. 145:5589–5597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nakamaki S, Satoh H, Kudoh A, Hayashi Y,
Hirai H and Watanabe T: Adiponectin reduces proteinuria in
streptozotocin-induced diabetic Wistar rats. Exp Biol Med
(Maywood). 236:614–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jenke A, Wilk S, Löbel M, Stehr J, Poller
W, Eriksson U, Schultheiss HP, Scheibenbogen C and Skurk C:
Adiponectin inhibits toll-like receptor 4 mediated cardiac
inflammation and injury. J Am Coll Cardiol. 59:E15502012.
View Article : Google Scholar
|
|
57
|
Martinon F, Pétrilli V, Mayor A, Tardivel
A and Tschopp J: Gout-associated uric acid crystals activate the
NALP3 inflammasome. Nature. 440:237–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sánchez-Lozada LG, Tapia E, Avila-Casado
C, Soto V, Franco M, Santamaria J, Nakagawa T, Rodriguez-Iturbe B,
Johnson RJ and Herrera-Acosta J: Mild hyperuricemia induces
glomerular hypertension in normal rats. Am J Physiol Renal Physiol.
283:F1105–F1110. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mazzali M, Hughes J, Kim YG, Jefferson JA,
Kang DH, Gordon KL, Lan HY, Kivlighn S and Johnson RJ: Elevated
uric acid increases blood pressure in the rat by a novel
crystal-independent mechanism. Hypertension. 38:1101–1106. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang C, Pan Y, Zhang QY, Wang FM and Kong
LD: Quercetin and allopurinol ameliorate kidney injury in
STZ-treated rats with regulation of renal NLRP3 inflammasome
activation and lipid accumulation. PLoS One. 7:e382852012.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang ZV, Schraw TD, Kim JY, Khan T, Rajala
MW, Follenzi A and Scherer PE: Secretion of the adipocyte-specific
secretory protein adiponectin critically depends on thiol-mediated
protein retention. Mol Cell Biol. 27:3716–3731. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Marek G, Pannu V, Shanmugham P, Pancione
B, Mascia D, Crosson S, Ishimoto T and Sautin YY: Adiponectin
resistance and proinflammatory changes in the visceral adipose
tissue induced by fructose consumption via ketohexokinase-dependent
pathway. Diabetes. 64:508–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Verzola D, Ratto E, Villaggio B, Parodi
EL, Pontremoli R, Garibotto G and Viazzi F: Uric acid promotes
apoptosis in human proximal tubule cells by oxidative stress and
the activation of NADPH oxidase NOX 4. Plos One. 9:e1152102014.
View Article : Google Scholar : PubMed/NCBI
|
